In the first wave of speaker announcements, we can confirm that leading academics from the US, Japan, Australia and Singapore will address the inaugural event, held at the Hilton Hotel from October 11-13.
‘Cancer treatments, the intestinal microbiome and probiotics’ will be the topic assessed by Prof Luis Vitetta, the director of Medical Research at the University of Sydney Medical School.
Assoc Prof Lynne V. McFarland, from the Department of Medicinal Chemistry at the University of Seattle, will examine the ‘Efficacy of single- or multi-strain probiotic mixtures’, while Dr Bejit Ideas, president of the Japanese Society of Anti-Ageing Nutrition, will look at the latest developments in probiotics and skin health.
Assoc Prof Liu Shao Quan, from the Food Science and Technology Programme at the National University of Singapore, will then reveal how his team are ‘Enabling the survival of probiotics in beer — Overcoming three key hurdles’.
Earlier this month, we reported how Assoc Prof Liu is now seeking industry partners to commercialise the beer.
NutraIngredients-Asia editor-in-Chief Gary Scattergood said: “I’m thrilled that we are bringing our Probiota summit, which has proved so successful in Europe and the US, to Singapore.
“Probiota has always been about connecting science and business in probiotics and prebiotics — providing that central point of exchange — and we are excited about what we have in store our for the event later this year with our partner, the International Probiotics Association.”
In the next wave of speaker announcements, we’ll unveil the industry speakers who will be participating, with high-level insights set to be delivered by representatives from Danone, Morinaga, Blis and DuPont, among others.
Meanwhile, researchers and those engaged in all aspects of microbiome science in academia, industry and consumer health are now being urged to submit abstracts to the scientific committee.
Successful authors will be invited to present their work either as an oral presentation or in a poster at Probiota Asia.
Those whose abstracts are accepted as posters will receive a 50% discount on their registration for the conference.
Early-phase, novel, or state-of-the-art research or promising ideas covering the following topics are encouraged, including:
- Host-microbe interactions in health and disease, including preclinical and clinical studies evaluating pre- and probiotic interventions
- Application and development of “-omics” approaches in biomarker discovery, including identification of potential pre- and probiotic strains. Research identifying strain-specific effects of probiotics for health and wellbeing, including mechanism of action, and bioactive discovery and isolation
- Early findings from large-scale research projects and clinical trials
- Innovations and novel ideas in the areas of production processes, delivery, formulation and shelf-life
- Consumer and market insights, including population research, trends and threats, and commercial packaging and marketing
- Human intervention studies
Any questions about the abstract submission process can be addressed to Dr Gemma Pearce at firstname.lastname@example.org.
The full abstract guidelines can be found here.
Register as a delegate here.